609367-72-8 Usage
Uses
Used in Pharmaceutical Industry:
[(S)-2,2-Dimethyl-1-(pyrrolidine-1-carbonyl)-propyl]-carbamic acid benzyl ester is used as a reagent in organic synthesis for the production of pharmaceuticals. Its unique structure and properties contribute to the development of new medicines and research in the pharmaceutical field.
Used in Drug Synthesis:
In the pharmaceutical industry, [(S)-2,2-Dimethyl-1-(pyrrolidine-1-carbonyl)-propyl]-carbamic acid benzyl ester is used as a building block in the synthesis of various drugs, leveraging its chiral nature to create specific drug candidates with desired therapeutic effects.
Used in Research and Development:
[(S)-2,2-Dimethyl-1-(pyrrolidine-1-carbonyl)-propyl]-carbamic acid benzyl ester is also utilized in research and development within the pharmaceutical field, where its unique structure aids in the exploration of novel drug candidates and the advancement of pharmaceutical science.
Check Digit Verification of cas no
The CAS Registry Mumber 609367-72-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,0,9,3,6 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 609367-72:
(8*6)+(7*0)+(6*9)+(5*3)+(4*6)+(3*7)+(2*7)+(1*2)=178
178 % 10 = 8
So 609367-72-8 is a valid CAS Registry Number.
609367-72-8Relevant academic research and scientific papers
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: Modification of the P2′ and P3′ side chains
Davies, Stephen J.,Ayscough, Andrew P.,Beckett, R. Paul,Clements, John M.,Doel, Sheila,Pratt, Lisa M.,Spavold, Zoe M.,Thomas, S. Wayne,Whittaker, Mark
, p. 2715 - 2718 (2007/10/03)
Structural modifications to the peptide deformylase inhibitor BB-3497 are described. In this paper, we describe the initial SAR around this lead for modifications to both the P2′ and P3′ side chains. Enzyme inhibition and antibacterial activity data revealed that a variety of substituents are tolerated at the P2′ and P3′ positions of the inhibitor backbone. The data from this study highlights the potential for modification at the P2′ and P3′ positions to optimise the physicochemical properties.
